Workflow
微创医疗再涨超7% 上海国资成为重要战略股东 公司完成25年上半年利润承诺

Group 1 - MicroPort Medical (00853) shares increased by over 7%, currently up 6.47% at HKD 13.82, with a trading volume of HKD 724 million [1] - On July 25, the largest shareholder, Otsuka Medical Devices, sold 15.71% of its 20.70% stake to several buyers, including Shanghai Maitake (7.31%), We'Tron Capital Limited (7.31%), and an investment platform affiliated with the management of MicroPort (1.08%) [1] - Northeast Securities noted that the restructuring of the major shareholder is expected to enhance business expansion and improve corporate governance; the introduction of state-owned investors as strategic shareholders is anticipated to support the company's core business development and strategic acquisition capabilities [1] Group 2 - The company has released its mid-term performance forecast, indicating that it has met the profit commitment for the first half of 2025, with expectations for continued improvement in profitability in the second half of 2025 [1] - The anticipated profit for the second half of 2025 is USD 0.52 billion to satisfy the terms of the convertible bond financing agreement [1]